Tabrecta Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Description

Tabrecta 150 mg film-coated tablets: Each film-coated tablet contains 150 mg of capmatinib (as capmatinib dihydrochloride monohydrate).
Tabrecta 200 mg film-coated tablets: Each film-coated tablet contains 200 mg of capmatinib (as capmatinib dihydrochloride monohydrate).
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose, Crospovidone, Magnesium stearate, Mannitol, Povidone, Anhydrous colloidal silica, Sodium laurilsulfate.
Film coating: Hypromellose, Black iron oxide (E172), Red iron oxide (E172), Yellow iron oxide (E172), Titanium dioxide (E171), Macrogol 4000, Talc.

capmatinib

Manufacturer:

Novartis

Distributor:

Zuellig Pharma